According to Flexion Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.10 B. In 2020 the company made a revenue of $85.55 M an increase over the years 2019 revenue that were of $72.95 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2021 (TTM) | $0.10 B | 17.36% |
2020 | $85.55 M | 17.26% |
2019 | $72.95 M | 223.91% |
2018 | $22.52 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 92,551.39% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 58,163.94% | ๐บ๐ธ USA |
Recro Pharma
REPH | $75.36 M | -24.94% | ๐บ๐ธ USA |
Pacira Biosciences
PCRX | $0.67 B | 572.29% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $0.65 M | -99.35% | ๐บ๐ธ USA |
Ampio Pharmaceuticals AMPE | N/A | N/A | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $20.96 M | -79.12% | ๐บ๐ธ USA |